Abstract --- Risk Evaluation and Mitigation Strategies (REMS) Solutions
Astir Analytics custom designs REMS solutions for pharmaceutical and biological product manufacturers. Risk Evaluation and Mitigation Strategies, or REMS, can be a complicated landscape for pharmaceutical companies, as it can take many forms. REMS requirements can be as simple as generating medication guides, or can be as complicated as providing certification training to medical professionals. Astir Analytics’ REMS solutions can help you meet your FDA mandated responsibilities
Astir Analytics is part of the Astir Family of Companies. Astir IT was founded in 2001 by 2 people and a vision. It began as a small home operation, but as time progressed and the reputation for excellence flourished, the business expanded quickly. Astir IT grew exponentially with every passing year and today we have over 300 employees across the United States, and have offices in New Jersey, California, and India.
Please be sure to visit the entire Astir Family of Companies at :